These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 21251587)

  • 1. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction.
    Lee ST; White AJ; Matsushita S; Malliaras K; Steenbergen C; Zhang Y; Li TS; Terrovitis J; Yee K; Simsir S; Makkar R; Marbán E
    J Am Coll Cardiol; 2011 Jan; 57(4):455-65. PubMed ID: 21251587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction.
    Gallet R; Tseliou E; Dawkins J; Middleton R; Valle J; Angert D; Reich H; Luthringer D; Kreke M; Smith R; Marbán L; Marbán E
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25953823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction.
    Kanazawa H; Tseliou E; Malliaras K; Yee K; Dawkins JF; De Couto G; Smith RR; Kreke M; Seinfeld J; Middleton RC; Gallet R; Cheng K; Luthringer D; Valle I; Chowdhury S; Fukuda K; Makkar RR; Marbán L; Marbán E
    Circ Heart Fail; 2015 Mar; 8(2):322-32. PubMed ID: 25587096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.
    Kanazawa H; Tseliou E; Dawkins JF; De Couto G; Gallet R; Malliaras K; Yee K; Kreke M; Valle I; Smith RR; Middleton RC; Ho CS; Dharmakumar R; Li D; Makkar RR; Fukuda K; Marbán L; Marbán E
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains.
    Tseliou E; Pollan S; Malliaras K; Terrovitis J; Sun B; Galang G; Marbán L; Luthringer D; Marbán E
    J Am Coll Cardiol; 2013 Mar; 61(10):1108-19. PubMed ID: 23352785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).
    Malliaras K; Makkar RR; Smith RR; Cheng K; Wu E; Bonow RO; Marbán L; Mendizabal A; Cingolani E; Johnston PV; Gerstenblith G; Schuleri KH; Lardo AC; Marbán E
    J Am Coll Cardiol; 2014 Jan; 63(2):110-22. PubMed ID: 24036024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.
    Smith RR; Barile L; Cho HC; Leppo MK; Hare JM; Messina E; Giacomello A; Abraham MR; Marbán E
    Circulation; 2007 Feb; 115(7):896-908. PubMed ID: 17283259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy.
    Johnston PV; Sasano T; Mills K; Evers R; Lee ST; Smith RR; Lardo AC; Lai S; Steenbergen C; Gerstenblith G; Lange R; Marbán E
    Circulation; 2009 Sep; 120(12):1075-83, 7 p following 1083. PubMed ID: 19738142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated transplantation of allogeneic cardiosphere-derived cells boosts therapeutic benefits without immune sensitization in a rat model of myocardial infarction.
    Reich H; Tseliou E; de Couto G; Angert D; Valle J; Kubota Y; Luthringer D; Mirocha J; Sun B; Smith RR; Marbán L; Marbán E
    J Heart Lung Transplant; 2016 Nov; 35(11):1348-1357. PubMed ID: 27342903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
    Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
    Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction.
    Makkar RR; Price MJ; Lill M; Frantzen M; Takizawa K; Kleisli T; Zheng J; Kar S; McClelan R; Miyamota T; Bick-Forrester J; Fishbein MC; Shah PK; Forrester JS; Sharifi B; Chen PS; Qayyum M
    J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):225-33. PubMed ID: 16382259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
    Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
    Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts.
    Qian HY; Yang YJ; Huang J; Gao RL; Dou KF; Yang GS; Li JJ; Shen R; He ZX; Lu MJ; Zhao SH
    Chin Med J (Engl); 2007 Aug; 120(16):1416-25. PubMed ID: 17825171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.
    Gallet R; Dawkins J; Valle J; Simsolo E; de Couto G; Middleton R; Tseliou E; Luthringer D; Kreke M; Smith RR; Marbán L; Ghaleh B; Marbán E
    Eur Heart J; 2017 Jan; 38(3):201-211. PubMed ID: 28158410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.
    Makkar RR; Smith RR; Cheng K; Malliaras K; Thomson LE; Berman D; Czer LS; Marbán L; Mendizabal A; Johnston PV; Russell SD; Schuleri KH; Lardo AC; Gerstenblith G; Marbán E
    Lancet; 2012 Mar; 379(9819):895-904. PubMed ID: 22336189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function.
    Houtgraaf JH; de Jong R; Kazemi K; de Groot D; van der Spoel TI; Arslan F; Hoefer I; Pasterkamp G; Itescu S; Zijlstra F; Geleijnse ML; Serruys PW; Duckers HJ
    Circ Res; 2013 Jul; 113(2):153-66. PubMed ID: 23658436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy.
    Yee K; Malliaras K; Kanazawa H; Tseliou E; Cheng K; Luthringer DJ; Ho CS; Takayama K; Minamino N; Dawkins JF; Chowdhury S; Duong DT; Seinfeld J; Middleton RC; Dharmakumar R; Li D; Marbán L; Makkar RR; Marbán E
    PLoS One; 2014; 9(12):e113805. PubMed ID: 25460005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
    Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
    J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary Administration of Allogeneic Cardiosphere-Derived Cells Immediately Prior to Reperfusion in Pigs With Acute Myocardial Infarction Reduces Infarct Size and Attenuates Adverse Cardiac Remodeling.
    Sousonis V; Sfakianaki T; Ntalianis A; Nanas I; Kontogiannis C; Aravantinos D; Kapelios C; Katsaros L; Nana M; Sampaziotis D; Sanoudou D; Papalois A; Malliaras K
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):88-99. PubMed ID: 32677460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.